Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
amorphous calcium carbonate/ Placebo
Universal Integrated
Calcium
1 trial -
cipher prescription 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Percutaneous Coronary Artery Intervention
1 trial -
esketamine group
The First People's Hospital of Lianyungang
Postherpetic Neuralgia
1 trial -
foundational treatment
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
intravenous immunoglobulin
The First People's Hospital of Lianyungang
Guillain-Barre Syndrome
1 trial -
iodine-containg spareribs soup
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Iodine Bioavailability
1 trial -
low-dose stem cell gel group
The First People's Hospital of Lianyungang
Burn Injury
1 trial -
modified BEAM
The First People's Hospital of Lianyungang
Autologous Stem Cell Transplantation
1 trial -
placebo
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
PCOS- Polycystic Ovary Syndrome
1 trial -
routine aspirin and heparin treatment
The First People's Hospital of Lianyungang
Acupuncture
1 trial -
simiaowan
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gout Flare
1 trial -
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
The First People's Hospital of Lianyungang
Gastrointestinal Stromal Tumors
1 trial -
traditional chinese medicine Xuanfei-Zhike formula
The First People's Hospital of Lianyungang
Cough Variant Asthma
1 trial -
treatment with or without colistin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carbapenem-Resistant Enterobacteriaceae Infection
1 trial -
warfarin
Hospital Authority, Hong Kong
Deep Venous Thromboembolism
1 trial -
zanubrutinib 160 mg BID orally
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma
1 trial -
Ξ³-globin reactivated autologous hematopoietic stem cells
The First People's Hospital of Lianyungang
Thalassemia Major
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources